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Since the early 1980’s over 40 million individuals have 
infected with HIV worldwide and over 12 million have 
died. In China by 2009 there had been 319,877 cases 
were identified as HIV/AIDS.1 AIDS has become not 
only a severe medical problem but also a social and 
economic issue. 
In 1996, protease inhibitor therapy became widely 
available for use in the treatment of HIV infection, thus a 
decline in HIV-related morbidity and mortality had been 
reported. Over the last decade, more and more Chinese 
HIV/AIDS patients turn to seek TCM treatment, among 
the reasons commonly cited for the use of TCM by 
patients with HIV infection are: expectation of good 
effect, reduction of symptoms from the disease or 
reduction of medicine side effect, or desire for 
improvement of quality of life and control over the 
disease process. The authors have reviewed the major 
developments and future challenges in HIV/AIDS 
treatment with TCM in recent years. 
TCM & AIDS 
Since AIDS is a “new” disease, found in 1981, there was 
no specific research on the disease in the past or in the 
classics. AIDS is an infectious and epidemic disease 
which is similar to Wen Yi (pestilence) or Xu Lao 
(consumptive disease) in TCM in terms of the way of 
spreading, epidemic conditions, characteristics of the 
onset and clinical manifestations. This kind of relativity 
provides theoretical basis as well as clinical experience 
for the treatment of AIDS with Chinese medicine. AIDS 
is a complicated syndrome with the symptoms excess, 
and root cause deficiency, marked by various and 
changeable symptoms and signs. TCM is able to analyze 
the pathological changes and make syndrome 
differentiation based on which the principle of treatment 
is set up and prescription worked out. 
It is said that “Western medicine treats the disease, 
Chinese medicine treats the patient”. When HIV 
infection occurs in someone, who has enough vital force 
and strong adjustment ability, he might be living 
concurrently with infection and becomes a long-time 
HIV carrier, with a retarded entering from asymptomatic 
stage to AIDS stage. TCM puts stress on the reactivity 
and adaptability of the organism to pathogens. In TCM, 
patients are treated with different therapies, including 
Chinese drugs, acupuncture, moxibustion, and Qigong 
exercise for enhancing the immune function of the 
organism, blocking the development, retarding the 
initiation (the progression from asymptomatic stage to 
the AIDS stage), or alleviating the symptoms and signs 
of the disease, so as to elevate the quality of life and 
prolong the life span of patients. The best time of 
intervening in AIDS with TCM is: For asymptomatic 
stage (HIV carrier) patients, the main purpose of 
treatment is to maintain and enhance the immune 
function so as to delay its progression to AIDS stage. For 
AIDS stage, TCM treatment focuses on relieving 
symptoms of patients who have AIDS-related 
opportunistic infection so as to improve the quality of 
life or combines with HAART therapy to alleviate the 
side effect of biomedical drugs.1 
Advances 
The antiretroviral have had an effect on reducing 
morbidity and mortality, prolonging lives and improving 
the quality of life (QoL) for many people living with 
HIV infection. However, HAART has some limits such 
as drug toxicities and cross-resistance among anti- 
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retroviral drugs of the same class. It is not so convenient 
for patients in rural areas to access the antiretroviral 
drugs, so alternative approaches are needed. TCM has 
been practiced for centuries for health care in China and 
is accepted gradually in the West. Over the past decade, 
evidence from experimental studies and clinical trials has 
demonstrated a positive association between use of TCM 
and immune promotion or symptom relief of people 
living with HIV/AIDS. Numerous observational studies 
and randomized controlled trials that compared herbal 
medicines or moxibustion with placebo or antiretroviral 
drugs in patients with HIV infection, HIV-related disease 
or AIDS have shown that Chinese herbs as well as 
acupuncture and moxibustion can reduce symptoms and 
signs of AIDS and opportunistic infections, and improve 
immune function and QoL. Significant improvement has 
been reported in AIDS patients with diarrhea and some 
gastrointestinal dysfunctions. Specifically, 3 double blind 
RCT trials reported that 6 months to 1 year of regular 
Chinese herb (Compound SH, Tangcao Tablets, 
Qiankunning Capsule) application could significantly 
reduce HIV RNA level in the treatment group than that 
in the placebo group.2-4 The 11 RCT trials reported that 
Chinese herbal medicine could enhance the immune 
function of HIV-infected individuals and AIDS patients. 
For instance, ZY-4 could increase CD4 cell count.5 The 
47 observational studies proved the beneficial effect of 
Chinese herb on immune function enhancement and 
symptoms alleviations (such as fatigue, cough, diarrhea 
and poor appetite), although bias might be inherent in 
these observational data.5 These studies above showed a 
variety of treatment principles of Chinese medicine like 
supplementing Qi and nourishing Yin, promoting Qi and 
activating blood circulation, clearing heat and 
eliminating dampness, removing toxic substance. 
Chinese herbs were also used to treat AIDS related 
diseases. The 13 RCT trials reported that Chinese herbal 
medicine was also effective for oral candidacies, 
peripheral neuropathy, skin rash, and diarrhea.6 For 
instance, Xiaomi Keli (消糜颗粒 Granule for Erosion 
Relief) may contribute to HIV-related oral candidacies, 
Duhuo Jisheng Tang (独活寄生汤  Decoction of 
Pubescent Angelica and Loranthus) may have an effect in 
improving peripheral neuropathy, Shenling Baizhu San 
(参苓白术散 Powder of Ginseng, Poria and Bighead 
Atractylodes) may contribute to HIV-related diarrhea, a 
promising gastrointestinal benefit was found from the 
Banxia Xiexin Tang (半夏泻心汤 Pinellia Decoction for 
Purging Stomach Fire). However, these findings still 
need to be confirmed in large, rigorous trials. The use of 
Chinese herbal medicines was associated with no or non- 
serious adverse effects. However, potential interaction 
between herbs and antiretroviral agents still need to be 
explored, although it was reported that Aining Granule 
may prolong the metabolic duration of anti-HIV drug 
indinavir in vivo. Chinese herb medicine may have some 
effect on chemical drugs through interacting with human 
liver CYP450.7 China’s current national guidelines 
updated in 2008 recommend ART initiation in all patients 
with CD4 cell count under 350 cells/mm3, this earlier 
initiation indicates that Chinese herbal medicine 
combined with HAART should be further studied. It is 
reported that Chinese herb Aizhi 1 prescription may 
effectively correct the abnormal fat distribution resulting 
from HAART, improve lipid conditions and increase 
CD4 count.8 Chinese herb “Kangaibaosheng capsule” 
may contribute to the restoration of immue function of 
AIDS patients, enhance the efficacy of HAART and 
improve QoL.9 
The 3 RCT trials reported that warming moxibustion at 
the main points: Shenque (CV 8), Guanyuan (CV 4), 
Zusanli (ST 36), Zhongwan (CV 12), Tianshu (ST 25) 
indicated good effect on AIDS patients with diarrhea.10-12 
Evidences from those trials suggested some beneficial 
effects of the use of herbal medicine and moxibustion for 
HIV infections and AIDS. However, considering the 
small sample and limitations of the trials (most of trials 
had participants less than 30, duration arranging from 3 
months to a year), more evidence from large, well- 
designed, rigorous trials is needed to give firm support. 
Therefore, future trials should be rigorous in 
methodology and address clinical outcomes such as PRO 
(patients reported outcome), QoL, or symptom relief. 
Participants should be stratified according to their stages, 
such as Asymptomatic HIV-infection, HIV-related 
diseases or AIDS. The quality of herbal medicine that is 
to be tested should be warranted through in vitro or in 
vivo experimental studies, and the adherence should be 
evaluated in the trials. An assessment system was 
preliminarily established to evaluate the effect of TCM in 
treating HIV/AIDS, including following aspects: 
subjective symptoms of patients, QoL, symptoms and 
signs concerned by physicians, clinical end points, 
biological parameters, which would be a good reflect on 
TCM efficacy.13 
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According to the regulation of SFDA in China, new 
Chinese patent medicine treating AIDS should be 
classified into anti-HIV patent that testified through in 
vitro and in vivo experiments and patent supplementary 
for AIDS treatment that either adds synergistic effect or 
alleviates toxic-side effect on antiretroviral drugs already 
existed. Tangcao Tablet is the first patent approved by 
SFDA for alleviating symptoms and signs of HIV/AIDS 
patients, 5 other relatively matured compounds 
(Qiankunning Tablets, Keaite Capsule, Chuankezhi 
Injection, Zhongyan-2 Granule and Compound 
Sanhuangsan) are still under clinical trials. 
Traditional Chinese Medicine intervention on HIV 
individual and AIDS patients started from 2004, a pilot 
project named National Free TCM HIV/AIDS Treatment 
Program had been launched by The State Administrative 
bureau of Traditional Chinese Medicine, and quickly 
scaled up from 5 provinces (Henan, Hebei, Anhui, Hubei, 
Guangdong) to 19 provinces, autonomous regions, and 
municipalities in China including some places with high 
prevalence, 9267 cases have been treated with TCM 
accumulatively. The therapeutic effects on 8946 cases 
from pilot project are as follows: most of the cases 
maintained stable immune function, main symptoms and 
signs like fever, cough, fatigue, poor appetite, diarrhea 
had significantly been relieved (P<0.001), no adverse 
reaction was found in TCM treatment. The authors 
reported the 3-year outcome on CD4+ lymphocyte count 
of 807 cases of HIV/AIDS enrolled in the program. The 
results showed that the overall CD4+ lymphocyte count 
maintained stable at the 6th month and the 12th month, 
declined significantly at the 18th month, 24th month and 
30th month, then elevated to the pre-treatment level at 
the 36th month. Patients with pre-treatment CD4+ 
lymphocyte count level <200/mm3, who possibly 
combined HAART therapy, had CD4+ lymphocyte count 
elevated significantly in after visits. Patients with 
pre-treatment CD4+ lymphocyte count level between 
200 and 350/mm3 maintained stable before the 36th 
month, and then rose significantly, which implicated the 
long-term effect of TCM. Patients with pre-treatment 
CD4+ lymphocyte count level >350/mm3, had CD4+ 
lymphocyte count declined significantly in after visits.14 
Challenge & Opportunity 
From 2008, State Major Science & Technology Specific 
Projects granted about 100 million on TCM research on 
HIV/AIDS, including research tasks such as “TCM 
syndrome differentiation in HIV/AIDS patients”, “TCM 
intervention of the asymptomatic HIV infected patients”, 
“TCM treatment of opportunistic infections and 
alleviating side-toxic effect of HAART in HIV/AIDS 
patients”, “TCM treatment on immune reconstitution 
after HAART in HIV/AIDS patients”, “Research on anti- 
HIV TCM animal model ”, “TCM efficacy assessment in 
HIV/AIDS patients”, “Establishment of good conditional 
clinical research base for HIV/AIDS treatment with 
TCM”, which presented opportunities as well as 
challenges to TCM researchers. Although TCM appears 
to be associated with the improvement in immune 
function, QoL, and some AIDS related opportunistic 
diseases, definitive conclusions were limited due to 
variation in designs, comparisons, heterogeneous 
outcomes and inadequate controls. High-quality, well- 
controlled, longer randomized trials are needed for 
further research. 
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